Testing Archives - COVIDRheum

Homepage Testing

Testing

COVID Rheum Patient Registry Form

March 23, 2020

Coming Soon COVID Rheum Patient Registry Form

Rituximab increased odds of COVID-19 hospitalization vs. DMARDs for patients with RA

Baseline use of rituximab compared with conventional synthetic disease-modifying antirheumatic drugs was associated with worse COVID-19 outcomes in patients with rheumatoid arthritis, according to a presenter at ACR Convergence 2021.“The COVID-19 pandemic led to several questions regarding the safety of DMARDs that patients with rheumatic diseases use for their management,” Namrata Singh, MD, MSCIFACP, assistant professor at the University of Washington, told Healio.Among different DMARDs, rituximab (Rituxan, Genentech) has a unique mechanism of action with depletion of B cells
DMARD interruptions in rheumatic disease persist despite reduced COVID-related anxiety

Despite a significant decrease in anxiety related to COVID-19, patients with autoimmune rheumatic disease continue to experience frequent interruptions in their medication use, according to survey data presented at ACR Convergence 2021.“We previously had found that many patients had their health care interrupted early in the pandemic and that patients frequently had stopped medications because of COVID-19 concerns,” Michael George, MD, MCSE, assistant professor of medicine and assistant professor of epidemiology in biostatistics and epidemiology at the Hospital of the University
Hydroxychloroquine prescribers 'should be vigilant' for potential cardiac toxicity

Rheumatologists who prescribe hydroxychloroquine or chloroquine should be aware of their potential cardiac toxicity, especially in high-risk patients with rheumatic disease, according to an American College of Rheumatology white paper.“We felt this article was important to address the knowledge and limitations in our knowledge of hydroxychloroquine (HCQ) and chloroquine (CQ) and the risk of potential adverse cardiovascular outcomes,” Julianna Desmarais, MD, of Oregon Health and Science University, in Portland, told Healio Rheumatology.“While these medications already have
‘Who do they call?’: Patient, provider education crucial for managing outpatient COVID-19

Pre- and post-exposure prophylaxis will be critical in managing outpatient COVID-19 infection in patients with immune-mediated conditions, according to speakers at ACR Convergence 2021.In a joint presentation, Cassandra Calabrese, DO, director of the Rheumatology-Infectious Disease Clinic and training program at the Cleveland Clinic, and Leonard H. Calabrese, DO, director of the RJ Fasenmyer Center for Clinical Immunology at the Cleveland Clinic, discussed the importance of education in patients with rheumatic diseases dwelling in the community.Leonard Calabrese pulled the lens out to the